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and Generating Controversy
For more than a half a century, biologists have upheld
the theory that in most mammalian species, oocytes
are formed before or shortly after birth, but never in
adulthood. This foundation of reproductive science has
survived the rapid growth of new technology and
knowledge and has remained virtually unchallenged
until two recent papers were published by the group
headed by Jonathan Tilly. The first paper claims that
mouse germline stem cells (GSCs) replace ovarian folli-
cles that have been rapidly lost through follicle death
(Johnson et al., 2004). The second paper, recently pub-
lished in Cell, proposes continuous immigration into
mouse ovaries of GSCs derived from bone marrow
(Johnson et al., 2005). How could so many investigators
have overlooked these basic mechanisms for so long,
or have they?
One of the major conclusions of their first paper—
that GSCs reside in the surface epithelium of mouse
ovaries and are active throughout life (Johnson et al.,
2004)—has now been modified by the authors them-
selves in their second paper (Johnson et al., 2005) in
response to several critical comments (Gosden, 2004;
Albertini, 2004; Greenfeld and Flaws, 2004; Telfer, 2004).
Indeed many of the experiments described in the first
paper are open to alternate explanations, and indepen-
dent corroboration of their conclusions has still to be
obtained. Here we express concerns about their sec-
ond paper regarding the putative role of bone marrow
cells in reproduction and the experimental rigor needed
to verify this revolutionary hypothesis.
Johnson et al. (2005) claim that “adult mouse ovaries
can produce hundreds of new oocytes within 24 hours”
after follicle destruction by doxorubicin. Oogenesis—
the process by which mitotic germ stem cells undergo
meiosis to the diplotene stage followed by the forma-
tion of follicles—normally requires at least one week
in the developing mouse ovary. It is astonishing if this
process can be completed within 24 hr as Johnson et
al. (2005) propose. To reconcile these observations, it
is important to test whether pre-existing follicles can
recover after doxorubicin treatment or whether new
germ cells undergoing accelerated oogenesis can be
identified and, in either case, whether the purported
oocytes are capable of supporting fertilization and sub-
sequent embryo development. Indeed it is central to
their hypothesis that the rates of meiosis and of follicle
formation are dramatically different and, therefore, it
falls upon these authors to show this experimentally.
The authors have also shown that molecular markers
normally associated with germ cells (Oct4, Mvh, Dazl,
Stella, and Fragilis) are expressed in blood and bone
marrow and, even more surprising, that expression
levels of these proteins vary during the mouse estrous
cycle. All of these proteins have been shown to be ex-
pressed in other cells and organs including brain andbone, so they cannot be considered germ cell markers;
rather, they should be considered as stem cell markers.
Such data based purely on RT-PCR are interesting but
do not prove that a reservoir of GSCs exists in extra-
ovarian sites. Besides, markers expressed by periph-
eral blood cells are likely to be detected in other or-
gans, thus the case for the exclusivity of these markers
in bone marrow is untenable. In future experiments, it
will be crucial to isolate candidate GSCs from various
organs for a detailed characterization of their pheno-
type and developmental potential.
Studies with cell markers in crude tissue extracts will
always be open to alternative interpretations, but trans-
plantation studies can produce more decisive results.
Johnson et al. (2005) have shown that transplantation
of bone marrow from normal donor mice appears to
regenerate follicles in the ovaries of young mice steri-
lized by combination chemotherapy and in those of the
congenitally sterile Atm mutant mouse. Some of these
new follicles were still present even as late as 11
months of age despite the small number shown to have
been formed initially.
Furthermore, by using transgenic animals overex-
pressing Oct4 linked to green fluorescent protein (GFP),
GFP-labeled oocytes were recognized in ovaries as
early as 28 to 30 hr after intravenous injection of nucle-
ated peripheral blood cells from the transgenic mice
into infertile female recipients. These results are cer-
tainly intriguing, but we are concerned that the authors
have not properly considered other explanations or
thoroughly examined the new putative germ cells. First,
there is a possibility that GFP could have been taken
up from the blood. This makes it essential to carry out
the reciprocal experiment to determine whether non-
GFP oocytes appear in Atm-Oct4/GFP mutant mouse
ovaries after injection of nucleated peripheral blood
cells from wild-type animals. Further studies of the lin-
eages of cell types migrating into the ovaries are also
needed, and these should use a nuclear rather than a
cytoplasmic label to track the cells. We emphasize
again the importance of verifying the fertility and origin
of “new” germ cells: the results published to date do
not even show that these new “oocytes” have entered
meiosis, far less that they can complete it and undergo
fertilization. Indeed, the Johnson et al. (2005) paper
raises two separate issues. The first is whether pluripo-
tent stem cells, such as those from bone marrow, are
able to develop into germ cell-like cells, and the second
is whether this mechanism of oocyte development ex-
ists in the normal functional ovary? It has already been
shown that the answer to the first is yes (Hubner et al.,
2003), but no evidence is presented to support the
second.
Although the authors are careful in the published pa-
per to restrict speculation beyond the data, in media
interviews following publication Jonathan Tilly pre-
sented an overly optimistic and enthusiastic vision with
respect to clinical applications and has suggested that
blood transfusion alone could solve infertility. “They’re
your own cells; you don’t need anybody’s approval.
Cell
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your ovaries, where they mature into eggs” (J. Tilly in
Goldberg, 2005). Although this speculation may be ex-
citing, it contradicts the experience to date of young
women undergoing medical treatments (comparable to
those given to mice in the Johnson et al. study) that
may render them infertile. Young cancer patients under-
going simple chemotherapy often exhibit a certain
amount of oocyte recovery, albeit with an earlier meno-
pause and a lower ovarian reserve. In contrast, the
stronger chemotherapy regimens that precede bone
marrow transplantation almost never result in oocyte
recovery. This clinical experiment has been ongoing for
the last two decades in humans undergoing bone mar-
row transplantation to treat cancer. If the bone marrow
contained putative oogonial stem cells, why do these
patients not usually recover ovarian function?
At a time when radical and far-reaching discoveries
are commonplace and old assumptions are sometimes
overturned, we should be prepared for unexpected re-
sults. Whether the hypothesis of Johnson et al. (2005)
proves to be a blind alley of science or to have dramatic
implications for medicine and animal reproduction will
depend on whether their findings can be extended as
outlined above and independently corroborated. On the
basis of the evidence so far, we find their conclusions
from their mouse model not proven and extrapolation
of the data to humans premature. Moreover, we are
concerned that their hypothesis is less reconcilable
with pure reason and human biology than conventional
theory. Stem cells are characterized by an indefinite life
span and proliferative potential, but, according to their
hypothesis, the phenomena of menopause and oocyte
aging may be attributable to bone marrow senescence.
Although modern biology has made us more accus-
tomed to the variety and plasticity of living systems, a
finite stock of oocytes formed early in life still seems to
better account for our current understanding of ovar-
ian physiology.
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